Protocol for pilot RCT of neuromodulation-augmented balance training in ambulatory people with multiple sclerosis
This article presents the protocol for a pilot randomized trial (NCT07174973) testing whether non-invasive neuromodulation can augment task-specific balance training in ambulatory people with multiple sclerosis (PwMS). Balance impairment and falls are common in PwMS and contribute to mobility limitations and reduced participation; FES and TSS have shown promise in other neurological populations but have not been studied alongside balance training in this group.
Twenty-four ambulatory PwMS will be randomly assigned to one of three arms: visual feedback balance training (VFBT) with sham stimulation; VFBT with active closed-loop FES to the ankle muscles plus sham TSS; or VFBT with active FES plus active open-loop sub-motor-threshold TSS delivered at the lumbosacral enlargement. Each participant will complete 12 training sessions over six weeks.
Feasibility, safety, and acceptability will be assessed via recruitment and adherence metrics, adverse-event monitoring, and semi-structured interviews guided by the Technology Acceptance Model questionnaire-2. Preliminary efficacy outcomes include performance-based measures of balance, mobility, and walking speed, alongside patient-reported outcomes covering balance confidence, walking ability, and fear of falling. Neuroplasticity will be probed through motor evoked potentials and spinal motor evoked potentials.
No clinical results, adverse-event rates, or efficacy estimates are reported in this abstract — the publication describes methodology only. The authors state that findings will help determine whether neuromodulation-augmented balance training is feasible, safe, and acceptable for PwMS and will inform the design of a future fully powered RCT. Clinicians should treat this as a trial-in-progress registration rather than evidence to change practice.